Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-19

Clinical Trial Update: Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of ezetimibe, simvastatin, or their combination on LDL subfractions in patients with type 2 diabetes mellitus and hyperchol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)
  • SIMVASTATIN (SIMVASTATIN)
  • ezetimibe/simvastatin (ezetimibe/simvastatin)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Diabetes Mellitus Type 2, Hypercholesterolemia | Phase 4 | Status: COMPLETED